(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Birds Will Flock To Your Birdbath When You Plant These Two Flowers Around It - 2A volcanic eruption may have catalyzed the plague's arrival in Europe, study suggests
- 3Modern surgery began with saws and iron hands – how amputation transformed the body in the Renaissance
- 4Must-Sit in front of the Programs from Europe and the US
- 5'Always put others first': IDF reservist who died while on leave saves four with organ transplants
- Baikonur launch pad damaged after Russian Soyuz launch to International Space Station
- Top Fascinating Organic products: Which One Might You Want to Attempt?
- HGV driver recruited others to smuggle migrants
- Step by step instructions to Look at Compact disc Rates: A Thorough Aide
- Ariana Grande and Jonathan Bailey will reunite for 'Sunday in the Park With George'
- Pope Leo XIV calls for urgent climate action and says God’s creation is 'crying out'
- Famous Rough terrain Vehicles for 2024
- The Forgotten BMW Coupe That Turned a 5 Series Into Something Far More Exotic
- Scientists reveal earliest evidence for shifting of Earth’s crust
